44 PRIMECAP Management Lilly(Eli) & Trades
PRIMECAP Management's position in Lilly(Eli) & is currently worth $17.1 Billion. It makes up 12.72% of their stock portfolio and is their biggest holding. The investor owns 2.38% of the outstanding Lilly(Eli) & stock. The first Lilly(Eli) & trade was made in Q1 2013. Since then PRIMECAP Management bought shares twelve more times and sold shares on 31 occasions. The stake costed the investor $1.24 Billion, netting the investor a gain of 1277% so far.
News about Lilly(Eli) & Co and PRIMECAP Management
Eli Lilly: Diabetes And Weight Management Treatments Are The Winning Tickets
No summary available.
Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million
Avalo acquires Phase 2-ready anti-IL-1β mAb, AVTX-009, through acquisition of AlmataBio, Inc. Topline results from planned Phase 2 trial in hidradenitis supp...
Eli Lilly Taps Amazon to Deliver Its Weight Management Blockbuster. Is It Time to Buy the Pharma Stock?
Free two-day shipping for Prime members and a direct-to-consumer sales model could accelerate sales of Eli Lilly''s Zepbound.
Dock Street Asset Management Inc. Lowers Stock Position in Eli Lilly and Company (NYSE:LLY)
Dock Street Asset Management Inc. lowered its position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 15.7% in the 3rd quarter, according to ...